Timothy R. Cote

Insider Reports History

Location
Washington, DC
Signature
/s/ Timothy R. Cote
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy R. Cote:

Company Role Class Num Shares Value Price $ Report Date Ownership
SOLIGENIX, INC. Director Common Stock 25,317 $12,659 $0.5000 03 May 2023 Silk Road Therapeutics, Inc.
SOLIGENIX, INC. Director Stock Option (Right to Buy) 15,000 03 May 2023 Direct

Insider Reports Filed by Timothy R. Cote

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNGX SOLIGENIX, INC. 03 May 2023 1 $0 4 Director 05 May 2023, 18:38
SNGX SOLIGENIX, INC. 03 May 2023 0 $0 3 Director 05 May 2023, 18:25